Print Page

藥 物 回 收

 
Canada: Recall: Sodium Acetate Injection, USP: Particulate matter (English Only)
 
Health Canada announces that Fresenius Kabi Canada Ltd. is recalling 2 lots of Sodium Acetate Injection, USP, 328 mg/ml (lot number: 6125334, 6125335) from wholesalers and healthcare establishments due to presence of particulate matter in the affected lots.

Please refer to the following website in Health Canada for details: http://recalls-rappels.canada.ca/en/alert-recall/sodium-acetate-injection-usp-particulate-matter

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Tuesday, Mar 8, 2022
Issued at HKT 13:00
 
Related Information:
Canada: Sodium Acetate Injection, USP: Potential for the presence of particulate... 上載於 2022-03-16
The United States: Fresenius Kabi issues voluntary recall of Sodium Acetate Inje... 上載於 2022-03-08
 
back